Why Medical Bills Still Bankrupt Americans—and How Other Countries Solved It

In the United States, a cancer diagnosis is frequently a dual crisis: a medical battle for survival and a financial struggle for solvency. While medical technology has advanced significantly, the American financial infrastructure supporting these treatments remains fragile. As of 2024, the discrepancy between the American healthcare experience and that of other high-income nations reflects a divergence in how economic security is maintained during illness.

Approximately 41 percent of U.S. adults reported having some form of medical debt as of 2024, according to the Kaiser Family Foundation. This affects roughly 100 million people—a population larger than Germany’s—struggling to pay for the cost of treatment. Data indicates that medical issues are cited in approximately 66 percent of all personal bankruptcies. This financial pressure creates a significant economic drag, as debt-burdened households reduce spending in other sectors, and the fear of losing health coverage limits labor mobility and entrepreneurship.

The American economy produces a robust average hourly earnings figure of $34.91 as of mid-2024, according to the Bureau of Labor Statistics. However, the U.S. is an outlier in how it translates that income into health security. For many workers, healthcare access is contingent upon specific employment arrangements. In contrast, peer nations provide a social floor designed to prevent medical expenses from leading to household insolvency. This stability allows for greater economic flexibility, as citizens can change jobs or start businesses without the immediate threat of losing essential health protections.

The Mechanics of the Single-Payer Engine

Taiwan provides a notable model for comparison. In 1995, the nation launched its National Health Insurance (NHI) program, a single-payer system that now covers over 99.9 percent of the population. Before the NHI, nearly half of Taiwan’s citizens were uninsured; today, medical bankruptcy as a result of primary care costs has been largely mitigated.

A primary driver of this stability is the reduction of administrative friction. In the U.S., administrative costs—encompassing billing, insurance negotiations, and debt collection—consume between 15 and 30 percent of total health spending. In Taiwan, that figure is approximately 1 percent, according to the Taiwan Ministry of Health and Welfare’s 2024 statistics.

Taiwan utilizes a high-tech “Smart Card” system to achieve this efficiency. Every citizen carries a card containing their encrypted medical history. When a patient visits a provider, the card is swiped, records are updated, and the government is billed automatically. This system reduces duplicate testing and minimizes the need for intermediary billing services.

However, this high-efficiency model carries distinct trade-offs. According to health policy analysis, the “high volume, low price” nature of the NHI has led to physician burnout and exceptionally short consultation times, often referred to as “three-minute outpatient” visits. Furthermore, Taiwan faces a looming solvency challenge; as the population ages and the cost of new medical technologies rises, the government must frequently navigate the political difficulty of raising premium rates to keep the system funded.

While the U.S. spent approximately 16.6 percent of its GDP on healthcare in 2023, Taiwan achieved universal coverage with a total expenditure of roughly 6.6 percent of GDP. This efficiency impacts the consumer directly: an MRI scan that averages over $1,100 in the U.S. costs approximately $150 in Taiwan.

The Chronic Illness Shield

France utilizes a different mechanism focused on social stability. The French healthcare system is structured so that financial responsibility decreases as the severity of the illness increases.

The Affections de Longue Durée (ALD) scheme is central to this approach. For 30 major chronic illnesses, including cancer, diabetes, and heart disease, the French National Health Insurance Fund provides 100 percent coverage. This ensures that patients with the highest health needs face zero out-of-pocket costs for their primary treatments, preventing the catastrophic accumulation of debt.

France’s out-of-pocket healthcare spending is among the lowest in the world, at approximately 9.3 percent of total expenditure as of 2023, according to OECD data. In 2021, the government expanded this with the “100% Santé” reform, which provides full reimbursement for audiology, optics, and dental prosthetics—medical needs that frequently drive American families into high-interest credit card debt. According to consumer data, American households with medical debt are twice as likely to skip basic necessities like food or rent compared to those without such debt.

Source: International Federation of Health Plans / OECD, 2024

Unlike the U.S., where coverage is often a binary between “insured” and “uninsured,” France utilizes a layered approach. The state covers the bulk of costs, and approximately 95 percent of the population holds mutuelles—non-profit supplementary insurance—to cover remaining costs for minor ailments. This structure keeps total per-capita costs significantly lower than in the U.S. while neutralizing the threat of medical bankruptcy.

Australia’s Hybrid Safety Net

Australia provides a third alternative: a hybrid system that offers a robust public floor alongside a private market. All Australians are covered by Medicare, funded primarily through a 2 percent tax on income.

The system includes explicit financial safety nets. The Pharmaceutical Benefits Scheme (PBS) sets a threshold for prescription costs. For general patients in 2024, once they spend approximately $1,647.90 on medicines in a calendar year, additional prescriptions for the remainder of the year are either free or significantly reduced in price. This prevents the “financial toxicity” often associated with modern drug regimens.

Furthermore, Australia’s “bulk billing” system allows doctors to accept the government rebate as full payment. In 2024, the Australian Institute of Health and Welfare reported that 76 percent of general practitioner consultations resulted in zero out-of-pocket costs for the patient. For an American earning the median wage, this level of predictability represents a significant departure from the standard experience of co-pays and unpredictable billing cycles.

The Economic Cost of Complexity

The impact of the American system extends beyond individual bills; it manifest as administrative friction and delayed care. The Commonwealth Fund’s 2024 “Mirror, Mirror” report ranked the U.S. last among 10 high-income countries in both administrative efficiency and affordability. Australia and France consistently rank in the top five.

The U.S. Consumer Price Index for all urban consumers reflects persistent inflationary pressures that exacerbate the weight of medical debt. In 2024, the Consumer Financial Protection Bureau (CFPB) moved to ban medical bills from credit reports, noting that medical debt is often a poor predictor of creditworthiness compared to traditional loans. Analysis from Families USA suggests that much of this debt is a byproduct of administrative complexity rather than just the direct cost of clinical care.

The lack of a centralized price-setting mechanism in the U.S. leads to wide fluctuations in costs. While Australia and Taiwan use government leverage to set prices for procedures and drugs, the U.S. market consists of thousands of different payors and providers, each with differing price schedules. This fragmentation creates a lack of transparency that complicates financial planning for both patients and employers.

Decoupling Health from Employment

The primary distinction between the U.S. and these peer nations is the establishment of a “social floor.” In the American model, healthcare is largely a benefit of employment. This creates a “job-lock” effect, where workers remain in suboptimal employment positions solely to maintain health coverage.

OECD research indicates that France and Australia demonstrate the feasibility of decoupling health security from specific employment while maintaining a role for private insurance. In these systems, citizens can opt for private care for faster access or premium amenities without sacrificing the underlying public guarantee that prevents financial ruin.

As the U.S. progresses through the mid-2020s, the health policy debate focuses increasingly on the economic consequences of medical debt. Data from Taipei, Paris, and Sydney suggests that providing a floor against medical insolvency is not merely a social policy, but an economic one. By reducing the financial risks associated with illness, these nations reduce the drag on their broader economies.

Economic policy is a reflection of how a nation manages its resources and risks. While the U.S. leads in high-end medical innovation, it continues to face challenges in the delivery of financial security. The evidence from international models suggests that a nation’s economic resilience is tied to the stability of the floor beneath its most vulnerable citizens. Until the U.S. addresses the structural causes of medical insolvency, the financial crisis following a diagnosis will continue to affect millions of households.